In current study toxicological profile of a commonly used herbal formulation was evaluated that is used extensively for gynecological disorders like menorrhagia, metrorrhagia, leucorrhea, irregular menstrual cycle, pre-menstrual syndrome and post-menopausal bleeding. It was also claimed to strengthen endometrium and ovaries. Since this herbal formulation was been used by a large number of population hence there was a need to assess acute and sub-chronic toxicity. Acute oral toxicity (LD50) was observed in albino mice using standard protocols whereas sub-chronic, hematological and histopathological studies were assessed on 24 albino rabbits after giving herbal formulation for 60 days in two doses (20 and 60 mg/kg) against control groups. The outcomes of present study showed that the drug is safe up to 5000 mg/kg following acute oral toxicity test and no mortality was observed during sub chronic toxicity studies. Results of sub-chronic toxicity did not show any significant changes in biochemical, hematological and histopathological parameters. However, some indicators such as urea, creatinine, hemoglobin, and RBC count were altered, but these changes do not correlate with the histopathological results and may be associated to intra individual variations. Despite the safety of the drug in few animals, clinical trials and more investigations on a large number of animals are essentially needed to establish safety and efficacy of the herbal formulation.
References
[1]
Farnsworth, N.R. (1988) Screening of Plants for New Medicines. In: Wilson, E.O., Ed., Chapter 9 in Biodiversity, National Academy Press, Washington DC.
[2]
Gurib-Fakim, A. (2006) Medicinal Plants: Traditions of Yesterday and Drugs of Tomorrow. Molecular Aspects of Medicine, 27, 1-93. http://dx.doi.org/10.1016/j.mam.2005.07.008
Khan, R.A., Arif, M., Sherwani, B. and Ahmed, M. (2013) Acute and Sub Chronic Toxicity of Mucuna pruriens, Cinnamomum zeylanicum, Myristica fragrans and Their Effects on Hematological Parameters. Australian Journal of Basic and Applied Sciences, 7, 641-647.
[5]
Drews, J. (2000) Drug Discovery: A Historical Perspective. Science, 287, 1960-1964. http://dx.doi.org/10.1126/science.287.5460.1960
[6]
Newman, D.J., Cragg, G.M. and Snada, K.M. (2000) The Influence of Natural Products upon Drug Discovery. Natural products Reports, 17, 215-234. http://dx.doi.org/10.1039/a902202c
[7]
Vickers, A. and Zollman, C. (1999) ABC of Complementary Medicine: Herbal Medicine. British Medical Journal, 319, 1050-1053. http://dx.doi.org/10.1136/bmj.319.7216.1050
De Smet, P.A.G.M. (1997) The Role of Plant-Derived Drugs and Herbal Medicines in Healthcare. Drugs, 54, 801-840. http://dx.doi.org/10.2165/00003495-199754060-00003
[10]
Miller, L.G. (1998) Hepatotoxic Herbs. Archives of Internal Medicine, 158, 2200-2210. http://dx.doi.org/10.1001/archinte.158.20.2200
[11]
Ernst, E. (2000) Possible Interactions between Synthetic and Herbal Medicinal Products. Part 1: A Systematic Review of the Indirect Evidence. Perfusion, 13, 4-15.
[12]
Ernst, E. (2000) Possible Interactions between Synthetic and Herbal Medicinal Products. Part 2: A Systematic Review of the Direct Evidence. Perfusion, 13, 60-70.
[13]
Skalli, S., Zaid, A. and Soulaymani, R. (2007) Drug Interactions with Herbal Medicines. Therapeutic Drug Monitoring, 29, 1-7. http://dx.doi.org/10.1097/FTD.0b013e31815c17f6
[14]
Subramoniam, A. (2001) The Problems and Prospects of Plant Drug Research in India: Pharmacological Evaluation of Ecotypes in Herbal Drug Development. Indian Journal of Pharmacology, 33, 145-146.
[15]
Kistorp, T.K. and Laursen, S.B. (2002) Herbal Medicines—Evidence and Drug Interactions in Clinical Practice. Ugeskr Laeger, 164, 4161-4165.
[16]
World Health Organization (1991) Guidelines for the Assessment of Herbal Medicines. Program on Traditional Medicines, Geneva, 1-4.
[17]
World Health Organization (2005) WHO Global Atlas of Traditional, Complementary and Alternative Medicine. World Health Organization, Geneva, 1-2.
[18]
Venugopal, S. (1998) Effect of Eve Care in Oligomenorrhoea. Antiseptic, 95, 329-330.
[19]
Pradhan, P., Joseph, L., Gupta, V., Chulet, R., Arya, H., Verma, R. and Bajpai, A. (2009) Saraca Asoca (Ashoka): A Review. Journal of Chemical and Pharmaceutical Research, 1, 62-71.
[20]
Bhutani, K.K., Jadhav, A.N. and Kalia, V. (2004) Effect of Symplocos racemosa Roxb. on Gonadotropin Release in Immature Female Rats and Ovarian Histology. Journal of Ethnopharmacology, 94, 197-200. http://dx.doi.org/10.1016/j.jep.2004.04.022
[21]
Jadhav, A.N. and Bhutani, K.K. (2005) Ayurveda and Gynecological Disorders. Journal of Ethnopharmacology, 97, 151-159. http://dx.doi.org/10.1016/j.jep.2004.10.020
[22]
Gilani, A.H., Khan, A.U., Jabeen, Q., Subhan, F. and Ghafar, R. (2005) Antispasmodic and Blood Pressure Lowering Effects of Valeriana wallichii Are Mediated through K+ Channel Activation. Journal of Ethnopharmacology, 100, 347-352. http://dx.doi.org/10.1016/j.jep.2005.05.010
[23]
Sahu, S., Ray, K., Yogendra, K.M.S., Gupta, S., Kauser, H., Kumar, S., Mishra, K. and Panjwani, U. (2012) Valeriana wallichii Root Extract Improves Sleep Quality and Modulates Brain Monoamine Level in Rats. Phytomedicine, 19, 924-929. http://dx.doi.org/10.1016/j.phymed.2012.05.005
[24]
Avallone, R., Zanoli, P., Corsi, L., Cannazza, G. and Baraldi, M. (1996) Benzodiazepine-Like Compounds and GABA in Flower Head of Matricaria chamomilla. Phytotherapy Research, 10, s177-s179.
[25]
Christoffel, V., Spengler, B., Jarry, H. and Wuttke, W. (1999) Prolactin Inhibiting Dopaminergic Activity of Diterpenes from Vitex Agnus Castus. In: Loew, D., Blume, H. and Dingermann, T., Eds., Phytopharmaka V, Springer-Verlag, Berlin Heidelberg, 209-214. http://dx.doi.org/10.1007/978-3-642-58709-2_25
[26]
van Diana, D., Burger, H.G., Teede, H. and Bone, K. (2012) Vitex Agnus-Castus Extracts for Female Reproductive Disorders: A Systematic Review of Clinical Trials. Planta Medica, 79, 562-575.
[27]
Gilani, A.H., Ghayur, M.N., Saify, Z.S., Ahmed, S.P., Choudhary, M.I. and Khalid, A. (2004) Presence of Cholinomimetic and Acetylcholinesterase Inhibitory Constituents in Betel Nut. Life Science, 75, 2377-2389. http://dx.doi.org/10.1016/j.lfs.2004.03.035
[28]
Peng, W., Liu, Y.-J., Wu, N., Sun, T., He, X.-Y. and Gao, Y.-X. (2015) Areca catechu L. (Arecaceae): A Review of Its Traditional Uses, Botany, Phytochemistry, Pharmacology and Toxicology. Journal of Ethnopharmacology, 164, 340-356. http://dx.doi.org/10.1016/j.jep.2015.02.010
[29]
Lorke, D. (1983) A New Approach to Practical Acute Toxicity Testing. Archives of Toxicology, 54, 275-287. http://dx.doi.org/10.1007/BF01234480
[30]
Larson, D.A. (1992) Analysis of Variance with Just Summary Statistics as Input. The American Statistician, 46, 151-152.
[31]
Akerele, O. (1993) Summary of WHO Guidelines for the Assessment of Herbal Medicines. Herbal Gram, 28, 13-19.
Tsai, H.H., Lin, H.W., Simon, A.P. and Mahady, G.B. (2012) Evaluation of Documented Drug Interactions and Contraindications Associated with Herbs and Dietary Supplements: A Systematic Literature Review. International Journal of Clinical Practice, 66, 1056-1078. http://dx.doi.org/10.1111/j.1742-1241.2012.03008.x
[34]
Chojnowska, I., Kucharczyk, K., Myszkowski, L., Radzikowski, A. and Szymańska, K. (1979) Blood Serum Proteins in Experimental Chronic Liver Injury in Rabbit. Patologia Polska, 30, 71-88.
[35]
Bonadonna, G. (1988) Chemotherapy Induced Complications. In: Bonadonna, G. and Robustelli-Della-Cuna, G., Eds., Handbook of Medical Oncology, 3rd Edition, Masson, Milano, Parigi, Barecellona and Mexico, 963-975.
[36]
Zimmerman, H.J. (1984) Function and Integrity of the Liver. In: Henry, J.B., Ed., Clinical Diagnosis and Management by Laboratory Methods, 17th Edition, W. B. Saunders, Philadelphia, 217-250.
